Mera Pharmaceuticals Inc MRPI:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 04/05/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date06/08/23
  • 52 Week Low0.00
  • 52 Week Low Date04/05/24

Key Stats

  • Market Cap557.30
  • Shares Out557.30M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta3.35
  • YTD % Change-99

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date06/08/23
  • 52 Week Low0.00
  • 52 Week Low Date04/05/24
  • Market Cap557.30
  • Shares Out557.30M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta3.35
  • YTD % Change-99

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-192,739.993
  • ROE (TTM)-
  • Revenue (TTM)302,630.007
  • Gross Margin (TTM)94.63%
  • Net Margin (TTM)-62.02%
  • Debt To Equity (MRQ)-6.01%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Mera Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mera Pharmaceuticals, Inc. is a marine biotechnology company. The Company focuses on photobioreactor technology and owns intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The Company manufactures natural astaxanthin from Haematococcus pluvialis microalgae. Through its research and development, the Company has formulated AstaFactor, an astaxanthin supplement with antioxidant and anti-inflammatory activity, which is available...
Benny Doro
President, Company Secretary, Interim Director
Charles Spaniak Sr.
Chief Financial Officer
Address
73-4460 Queen Kaahumanu Hwy Ste 110
Kailua-kona, HI
96740
United States